CompletedNot Applicable

Hypomagnesemia and Its Association With Calcineurin Inhibitors Use in Renal Transplant Recipients

Egypt80 participantsStarted 2022-05-10

Plain-language summary

To assess the prevalence and risk factors of hypomagnesemia and its association with calcineurin inhibitor use among Egyptian renal transplant recipients.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕. Serum creatinine more than 2.5 mg/dL.
✕. Patients on diuretics.
✕. Patients on magnesium supplementation.
✕. Patients with diabetes mellitus.
✕. Chronic alcoholism.
✕. Patients on proton pump inhibitors.

What they're measuring

decrease in serum magnesium

Timeframe: one month

Trial details

NCT IDNCT05352880

SponsorAlexandria University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-07-30

View on ClinicalTrials.gov More Renal Transplantation; Complication trials